Beta Drugs (NSE:BETA) 3-Year EBITDA Growth Rate : 34.70% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs 3-Year EBITDA Growth Rate?

Beta Drugs's EBITDA per Share for the six months ended in Sep. 2024 was ₹39.94.

During the past 12 months, Beta Drugs's average EBITDA Per Share Growth Rate was 13.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 34.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 38.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 96.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beta Drugs was 1047.50% per year. The lowest was 30.70% per year. And the median was 48.10% per year.

Competitive Comparison of Beta Drugs's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Beta Drugs's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Beta Drugs 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Beta Drugs (NSE:BETA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Beta Drugs 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Beta Drugs's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines